phytic acid has been researched along with bromodeoxyuridine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corazza, F; Harfi, I; Hayez, N; Lema-Kisoka, R; Sariban, E; Svoboda, M | 1 |
1 other study(ies) available for phytic acid and bromodeoxyuridine
| Article | Year |
|---|---|
The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells.
Topics: Adenosine Triphosphate; Bromodeoxyuridine; Calcium; Cell Line, Tumor; Cyclic AMP; Cytarabine; Cytosol; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Interactions; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Estrenes; Flow Cytometry; Glycophorins; Humans; Immunosuppressive Agents; Inositol Phosphates; Intercellular Adhesion Molecule-1; Leukemia; Myeloid Cells; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Protein Binding; Proto-Oncogene Proteins; Pyrrolidinones; Receptors, Vasoactive Intestinal Peptide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Thrombin; Time Factors; Transcription Factor AP-1; Vasoactive Intestinal Peptide | 2004 |